New Paste

Content

https://www.selleckchem.com/products/brigatinib-ap26113.html For locally advanced nasopharyngeal carcinoma (LA-NPC) patients, high incidences of distant metastases and severe treatment related toxicities are the main obstacles needed to be overcome. Raltitrexed, a specific thymidylate synthase inhibitor with a convenient administration schedule, has an acceptable and manageable toxicity, and possesses radio-sensitizing properties. To investigate the efficacy and safety of raltitrexed and cisplatin induction chemotherapy and concurrent chemoradiotherapy (IC+CCRT) in patients with LA-NPC, a phase II clinical study was conducted. Sixty eligible patients with LA-NPC were enrolled into this study. A raltitrexed-cisplatin combination was used as part of an IC+CCRT regimen. Raltitrexed-cisplatin IC was given once every 3 weeks (q3w) for two cycles, followed by raltitrexed-cisplatin based CCRT q3w for two cycles. Intensity-modulated radiotherapy (IMRT) was given for all enrolled patients. All patients were included in survival analysis according to the intent-to-treat principle. The objective response rate (ORR) 3 months after treatment was 98%. The 2-year overall survival (OS) rate was 92%. The median relapse-free survival (RFS) time was 30.5 [95% confidence interval (95% CI), 28.4-32.3] months. The 2-year RFS rate was 85%. The 2-year local failure-free survival (LFFS) rate was 97% and the 2-year distant metastasis-free survival (DMFS) rate was 88%. Acute toxicities were mostly grade 2 and 3 reactions in bone marrow suppression, gastrointestinal side effect and oropharyngeal mucositis. Only two patients occurred grade 4 acute toxicities, one was bone marrow suppression and the other was dermatitis radiation. The combination of raltitrexed and cisplatin has a comparable efficacy to those in standard first-line therapy. The combination of raltitrexed and cisplatin has a comparable efficacy to those in standard first-line therapy. The transanal approach to specimen collection

Optional Paste Settings

Title

Select folder or

Syntax Highlighting

Paste Expiration

Paste Status

Password

Description

Our statistics

Create and share texts quickly and easily 🚀

321,699+

Total pastes

164,894,607+

Total views

115+

Registered users

Our features

Everything you need 😉

Pastes creation

Create multiple posts quickly and easily with our powerful editor.

Folders

Store your pastes in different folders with custom names.

Paste protection

Protect your pastes with password, encryption and captcha.

Multiple syntax languages

We have 150+ syntax languages for your codes.

URL monetization

Earn money by enabling url shorteners in your pastes.

Global settings

Configure each aspect of your pastes globally.

Recent Pastes

Perihal Yang Penting Dikenali Tentang Taruhan Judi Online
HTML | 808 | 1 minute ago
teknik bisnis slots online internasional
HTML | 41 | 5 minutes ago
shared google xxx albums
HTML | 453 | 6 minutes ago
Tips To Help You Manage Your Credit Cards Wisely
HTML | 556 | 7 minutes ago
Ten Startups That Will Revolutionize The Soffit And Fascia Replacement
HTML | 603 | 8 minutes ago
HGF takes away septic endothelial harm through curbing pyroptosis thro
HTML | 1K | 8 minutes ago
Unbiased glial subtypes delay advancement and expand balanced lifetime
HTML | 1K | 9 minutes ago